Posted on 3/14/2011, 2:27:55 PM by Slyscribe
The market is in a correction. Earthquakes, floods and violence dominate the news. Investors should be cautious, but still looking for future prospects. Demand for health care keeps growing even in tough times. Seven medical stocks are part of the elite IBD 50, up from four just two weeks ago They include Amerigroup (AGP), HealthSpring (HS), Novo Nordisk (NVO), Edwards Lifesciences (EW), Perrigo (PRGO), ViroPharma (VPHM) and Endo Pharmaceuticals (ENDP).
(Excerpt) Read more at blogs.investors.com ...
One to watch but not included...Dendreon (DNDN)-
first autologous immunotherapy for prostate cancer, FDA approved...better survival rate than toxic chemo...with minimal side effects, no toxicity.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.